Acta Scientific Pharmacology (ASPC)

Letter to Editor Volume 1 Issue 3

hERG Gene: Towards the Pathophysiology Beyond Long QT

Firdous SM* and Arghya Bhattacharya

Department of Pharmacology, Calcutta Institute of Pharmaceutical Technology and Allied Health Sciences, Uluberia, Howrah, West Bengal, India

*Corresponding Author: Firdous SM, Associate Professor, Department of Pharmacology, Calcutta Institute of Pharmaceutical Technology and Allied Health Sciences, Uluberia, Howrah, West Bengal, India.

Received: February 16, 2020; Published: February 24, 2020

×

  hERG is human-ether-a-go-go-gene which codes for potassium channel. Mutation of the hERG gene decreases the efflux of potassium ions which lead to hyperpolarization of the cardiac cell causes prolonged QT syndrome [1]. Not only it causes QT prolongation, it sometimes increases effluxing more potassium ion which may lead to QT shortening. Beyond causing cardiac arrhythmia the expression of hERG gene in different cells of our body may introduce other diseases. It's overexpression cause disturbance in the cell cycle and boosts the expression biomarker for cancer. In MCF-7(breast cancer cell), the expression of hERG gene on this cell may develop cancer [2]. Experiments in gastric and ovarian carcinoma highlighted the overexpression of hERG gene in the S phase, whereas while interfering with G2 or M phase it produces endometrial cancer [3]. hERG expression with other biomarkers (TNFRI or CXCR4) produces neurological disorder. In pancreatic alpha and beta cells, the expression of hERG gene has been reported. Pharmacological antagonism of the channel in these cells appears to enhance glucose and arginine-induced insulin secretion and repress glucagon secretion under low glucose conditions by modulating transmembrane calcium fluxes. In the case of hepatic cells, the overexpression of hERG gene on the HepG2 cell cause E4031 inhibition, which leads to cell proliferation and fibrosis. Moreover, overexpression of hERG gene on LDL receptor cause decreases the metabolism lead to hyperlipidemia [4]. Thus, here we considered these other functions of hERG, particularly their impact on diseases beyond cardiac arrhythmia.

×

Citation

Citation: Firdous SM and Arghya Bhattacharya. “hERG Gene: Towards the Pathophysiology Beyond Long QT”. Acta Scientific Pharmacology 1.2 (2020):01-02.




Member In



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 15, 2020.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US